Table 2 Sociodemographic and clinical characteristics of enrolled patients. Sociodemographic and clinical characteristics of the patients at study enrolment
|  | Total sample N = 82 |
|---|---|
Female sex | 62 (75.6%) |
ANA positive | 60 (73.1%) |
HLA-B27 positive | 8 (9.8%) |
Rheumatoid factor positive | 7 (8.5%) |
Clinical JIA Characteristics (n = 82) | |
 Oligoarthritis, persistent | 44 (53.7%) |
 Oligoarthritis, extended | 9 (11.0%) |
 RF- Polyarthritis | 15 (18.3%) |
 Psoriatic arthritis | 1 (1.2%) |
 Enthesitis-related arthritis | 4 (4.9%) |
 Undifferentiated JIA | 4 (4.9%) |
 Unknown* | 5 (6.1%) |
 JIA disease duration, years, mean (SD) | 4.8 (3.8) |
 Age at disease onset in years, mean (SD) | 3.8 (3.2) |
 Physician’s global, VAS, mean (SD) (range 0–100) | 34.0 (28.7) |
Patient reported outcomes (n = 51) | |
 Number of days in hospital due to uveitis in the last 6 months | 12 (23.5%) |
 Missed days in kindergarten/ school due to uveitis in the last 6 months | 27 (52.9%) |
 Number of days with restrictions in daily life due to uveitis in the last 6 months | 12 (23.5%) |
 Patients assessment of overall well-being, VAS, mean (SD) (range 0–100) | 34.1 (29.7) |
 C-HAQ, mean (SD) (range 0–3) | 0.81 (1.04) |
 PedsQL, mean (SD) (range 0–100) | 78.7 (21.5) |
Clinical Uveitis Characteristics (n = 82) | |
 Uveitis disease duration, years, mean (SD) | 3.3 (3.0) |
 Age at uveitis onset in years, mean (SD) | 5.1 (2.9) |
Number of affected eyes | |
 unilateral | 17 (20.7%) |
 bilateral | 65 (79.3%) |
 Physician’s global, VAS, mean (SD) | 44.3 (34.1) |
 Number of patients with at least one active eye (AC cell grade > 0) | 82 (100.0%) |